Paladin Wealth’s Cardinal Health CAH Stock Holding History

Paladin Wealth’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,202	Closed	-$202K	–	114
2025 Q2	$202K	Buy	+1,202	New	+$178K	0.16%	111
2024 Q4	–	Sell	-1,513	Closed	-$167K	–	114
2024 Q3	$167K	Buy	+1,513	New	+$158K	0.15%	103

Other funds holding CAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Paladin Wealth's CAH Position: Q3 2025 in Review

Paladin Wealth sold out of Cardinal Health (CAH) in Q3 2025, closing a stake of 1,202 shares — an estimated $202K sold.

Paladin Wealth first reported a position in CAH in Q3 2024 and held it in 2 quarters. The position peaked at $202K in Q2 2025. 1,222 funds tracked by Wall St. Rank hold CAH as of Q3 2025.

Paladin Wealth reported no remaining Cardinal Health position as of Q3 2025 after selling out during the quarter.
Paladin Wealth sold 1,202 Cardinal Health shares in Q3 2025, an estimated $202K.
Paladin Wealth first reported a position in Cardinal Health in Q3 2024 and held it in 2 quarters.
Paladin Wealth's Cardinal Health position peaked at $202K in Q2 2025.
1,222 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2025.

Based on Paladin Wealth's 13F filing for Q3 2025, filed 14 Oct 2025.